Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe
- DOJ seen building accounting fraud case against company
- Former executives Pearson, Schiller also under scrutiny
DOJ Probes Valeant for Accounting Fraud
This article is for subscribers only.
U.S. prosecutors are focusing on Valeant Pharmaceuticals International Inc.’s former CEO and CFO as they build a fraud case against the company that could yield charges within weeks, according to people familiar with the matter.
Authorities are looking into potential accounting fraud charges related to the company’s hidden ties to Philidor Rx Services LLC, a specialty pharmacy company that Valeant secretly controlled, the people said. Federal prosecutors in Manhattan and agents at the Federal Bureau of Investigation in New York have been investigating the company for at least a year.